Format

Send to

Choose Destination
Prion. 2016 Sep 2;10(5):352-361.

Uncontrolled SFK-mediated protein trafficking in prion and Alzheimer's disease.

Author information

1
a Department of Biology , Universidad Peruana Cayetano Heredia , Lima , Perú.
2
b Department of Biology , University of Konstanz , Konstanz , Germany.

Abstract

Prions and Amyloid beta (Aβ) peptides induce synaptic damage via complex mechanisms that include the pathological alteration of intracellular signaling cascades. The host-encoded cellular prion protein (PrPC) acts as a high-affinity cell surface receptor for both toxic species and it can modulate the endocytic trafficking of the N-methyl D-aspartate (NMDA) receptor and E-cadherin adhesive complexes via Src family kinases (SFKs). Interestingly, SFK-mediated control of endocytosis is a widespread mechanism used to regulate the activity of important transmembrane proteins, including neuroreceptors for major excitatory and inhibitory neurotransmitters. Here we discuss our recent work in zebrafish and accumulating evidence suggesting that subversion of this pleiotropic regulatory mechanism by Aβ oligomers and prions explains diverse neurotransmission deficits observed in human patients and mouse models of prion and Alzheimer's neurodegeneration. While Aβ, PrPC and SFKs constitute potential therapeutic targets on their own, drug discovery efforts might benefit significantly from aiming at protein-protein interactions that modulate the endocytosis of specific SFK targets.

KEYWORDS:

Alzheimer disease; Aβ peptide; E-cadherin; NMDA receptor; Src family kinases; endocytosis; neurotransmission; prion protein; synaptic damage; zebrafish

PMID:
27649856
PMCID:
PMC5105932
DOI:
10.1080/19336896.2016.1221873
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Taylor & Francis Icon for PubMed Central
Loading ...
Support Center